The advent of immune-checkpoint inhibitors (ICI) in modern oncology has significantly improved survival in several cancer settings. A subgroup of women with breast cancer (BC) has immunogenic infiltration of lymphocytes with expression of programmed death-ligand 1 (PD-L1). These patients may potentially benefit from ICI targeting the programmed death 1 (PD-1)/PD-L1 signaling axis. The use of tumor-infiltrating lymphocytes (TILs) as predictive and prognostic biomarkers has been under intense examination. Emerging data suggest that TILs are associated with response to both cytotoxic treatments and immunotherapy, particularly for patients with triple-negative BC. In this review from The International Immuno-Oncology Biomarker Working Group, we discuss (a) the biological understanding of TILs, (b) their analytical and clinical validity and efforts toward the clinical utility in BC, and (c) the current status of PD-L1 and TIL testing across different continents, including experiences from low-to-middle-income countries, incorporating also the view of a patient advocate. This information will help set the stage for future approaches to optimize the understanding and clinical utilization of TIL analysis in patients with BC. (Group author: Int Immuno-Oncology Biomarker)

The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group / K. El Bairi, H.R. Haynes, E. Blackley, S. Fineberg, J. Shear, S. Turner, J.R. de Freitas, D. Sur, L.C. Amendola, M. Gharib, A. Kallala, I. Arun, F. Azmoudeh-Ardalan, L. Fujimoto, L.F. Sua, S.-. Liu, H.-. Lien, P. Kirtani, M. Balancin, H. El Attar, P. Guleria, W. Yang, E. Shash, I.-. Chen, V. Bautista, J.F. Do Prado Moura, B.L. Rapoport, C. Castaneda, E. Spengler, G. Acosta-Haab, I. Frahm, J. Sanchez, M. Castillo, N. Bouchmaa, R.R. Md Zin, R. Shui, T. Onyuma, W. Yang, Z. Husain, K. Willard-Gallo, A. Coosemans, E.A. Perez, E. Provenzano, P.G. Ericsson, E. Richardet, R. Mehrotra, S. Sarancone, A. Ehinger, D.L. Rimm, J.M.S. Bartlett, G. Viale, C. Denkert, A.I. Hida, C. Sotiriou, S. Loibl, S.M. Hewitt, S. Badve, W.F. Symmans, R.S. Kim, G. Pruneri, S. Goel, P.A. Francis, G. Inurrigarro, R. Yamaguchi, H. Garcia-Rivello, H. Horlings, S. Afqir, R. Salgado, S. Adams, M. Kok, M.V. Dieci, S. Michiels, S. Demaria, S. Loi, K. El Bairi, H.R. Haynes, E. Blackley, S. Fineberg, J. Shear, S. Turner, J.R. de Freitas, D. Sur, L.C. Amendola, M. Gharib, A. Kallala, I. Arun, F. Azmoudeh-Ardalan, L. Fujimoto, L.F. Sua, S.-. Liu, H.-. Lien, P. Kirtani, M. Balancin, H. El Attar, P. Guleria, W. Yang, E. Shash, I.-. Chen, V. Bautista, J.F. Do Prado Moura, B.L. Rapoport, C. Castaneda, E. Spengler, G. Acosta-Haab, I. Frahm, J. Sanchez, M. Castillo, N. Bouchmaa, R.R. Md Zin, R. Shui, T. Onyuma, W. Yang, Z. Husain, K. Willard-Gallo, A. Coosemans, E.A. Perez, E. Provenzano, P.G. Ericsson, E. Richardet, R. Mehrotra, S. Sarancone, A. Ehinger, D.L. Rimm, J.M.S. Bartlett, G. Viale, C. Denkert, A.I. Hida, C. Sotiriou, S. Loibl, S.M. Hewitt, S. Badve, W.F. Symmans, R.S. Kim, G. Pruneri, S. Goel, P.A. Francis, G. Inurrigarro, R. Yamaguchi, H. Garcia-Rivello, H. Horlings, S. Afqir, R. Salgado, S. Adams, M. Kok, M.V. Dieci, S. Michiels, S. Demaria, S. Loi, V. Schelfhout, E. Arbzadeh, A. Bondanar, S.A.G. Reyes, J.R. Ruz, J. Kang, L. Xiang, M. Zimovjanova, P. Togores, T. Ozturk, A. Patil, M. Corpa, A. Whitehouse, B. Tan, A. de Paula, C. Rossetti, C. Lang-Schwarz, S. Mahon, C. Giacometti, B. Linderholm, F. Deman, G. Montagna, G. Gong, M. Pavcovich, Y. Chaer, I.A. Cabrero, M.L. de Brito, N. Ilieva, A. Fulop, M. Souza, D. Bilancia, M. Idowu, R. Johri, J. Szpor, L. Bachani, F. Schmitt, M. Giannotti, Y. Kurebayashi, B.E.A. Ramirez, E. Salido, L. Bortesi, S. Bonetto, K. Elomina, P. Lopez, V. Sharma, A. Edirisinghe, D. Mathur, A. Sahay, M.A. Mouloud, C.H. Giang, E. Mukolwe, E. Kiruka, N. Samberg, N. Abe, M. Brown, E. Millar, X.B. Li, Z. Yuan, A. Pasupathy, R. Miele, R. Luff, M.M.A. e Porfirio, O. Ajemba, R. Soni, E. Orvieto, M. DiMaio, J. Thomas, R. Merard, M.M. Subramaniam, T. Apolinario, O. Preda, R. Preda, A. Makanga, M.S. Maior, L. Li, M. Saghatchian, T. Saurine, E. Janssen, J. Cochran, N. Vlada, R. Cappellesso, K. Elfer, M. Hollick, S. Desai, G. Oner, A. Schreurs, S. Liu, R. Perera, P. Mercurio, F. Garcia, K. Hosny, H. Matsumoto, C. van Deurzen, G. Bianchini, I. Coban, A. Jahangir, A. Rahman, D. Stover, P. Luz, A. Martel, Y. Waumans, A. Stenzinger, J. Cortes, P. Dimitrova, I. Nauwelaers, M. Velasco, F. Fan, G. Akturk, M. Firer, I. Roxanis, M. Schneck, H. Wen, V. Cockenpot, A. Konstantinov, A. Calatrava, M.N. Vidya, H.J. Choi, P. Jank, A.H. CIinen, D. Sabanathan, G. Floris, D. Hoeflmayer, T. Hamada, N. Laudus, A. Grigoriadis, I. Porcellato, B. Acs, F. Miglietta, J. Parrodi, D. Clunie, B. Calhoun, F.-. Lu, A. Lefevre, S. Tabbarah, W. Tran, I. Garcia-murillas, P. Jelinic, C. Boeckx, S. Souza, M.C. Cebollero, E. Felip, J.L.S. Rendon, E. El Gabry, J. Saltz, E. Bria, G. Garufi, J. Hartman, M. Sebastian, H. Olofsson, L. Kooreman, J. Cucherousset, M.-. Mathieu, C. Ballesteros-Merino, P. Siziopikou, J. Fong, M. Klein, I.R.I. Qulis, J. Wesseling, E. Bellolio, J.C. Araya, S. Naber, M. Cheang, I. Castellano, A. Ales, A.-. Laenkholm, J. Kulka, C. Quinn, A. Sapino, I. Amendoeira, C. Marchio, J. Braybrooke, A. Vincent-Salomon, K.P. Korski, M. Sofopoulos, E.I.S. Stovgaard, S. Bianchi, Z. Bago-Horvath, C. Yu, P. Regitnig, S. Hall, Z. Kos, S. Sant, J.-. Tille, B. Gallas, D. Bethmann, P. Savas, L. Mendes, T. Soler, M. van Seijen, T. Gruosso, A. Quintana, J. Giltnane, G. Van den Eynden, E. Duregon, R. de Cabo, P.C. Recamo, L. Gaboury, J. Zimmerman, C.S. Pop, A. Wernicke, D. Williams, A. Gill, B. Solomon, B. Thapa, G. Farshid, L. Gilham, M. Christie, S. O'Toole, S. Hendry, S.B. Fox, S.J. Luen, S.R. Lakhani, T. Fuchs, T. John, I. Brcic, J. Hainfellner, L. Sigurd, M. Preusser, P. Poortmans, A. Decaluwe, C. Carey, C. Colpaert, D. Larsimont, D. Peeters, G. Broeckx, K. van de Vijver, L. Buisseret, L. Dirix, M. Hertoghs, M. Piccart, M. Ignatiadis, M. Van Bockstal, N. Sirtaine, P. Vermeulen, R. de Wind, S. Declercq, T. Gevaert, B. Haibe-Kans, B.H. Nelson, P.H. Watson, S. Leung, T. Nielsen, L. Shi, E. Balslev, J. Thagaard, A. Almangush, A. Makitie, H. Joensuu, J. Lundin, D. Drubay, E. Roblin, F. Andre, F. Penault-Llorca, J. Lemonnier, J. Adam, M. Lacroix-Triki, N. Ternes, N. Radosevic-Robin, F. Klaushen, K. Weber, N. Harbeck, O. Gluz, S. Wienert, G. Cserni, A. Vingiani, C. Criscitiello, C. Solinas, G. Curigliano, E. Konishi, E. Suzuki, K. Yoshikawa, K. Kawaguchi, M. Takada, M. Toi, M. Ishida, N. Shibata, S. Saji, T. Kogawa, T. Sakatani, T. Okamoto, T. Moriya, T. Kataoka, T. Shimoi, T. Sugie, T. Sugie, T. Mukohara, Y. Shu, Y. Kikawa, Y. Kozuka, S. Sayed, R. Rahayu, R. Ramsaroop, E. Senkus-Konefka, E. Chmielik, F. Cardoso, J. Ribeiro, J. Chan, R. Dent, M. Martin, C. Hagen, A. Guerrero, F. Rojo, L. Comerma, P. Nuciforo, V.V. Serrano, V.P. Camaea, T. Steenbruggen, F. Ciompi, I. Nederlof, H. Jan, J. van der Laak, J. van den Berg, L. Voorwerk, M. van de Vijver, M. de Maaker, S. Linn, H. McKenzie, N. Somaiah, A. Tutt, C. Swanton, C. Hiley, D.A. Moore, J.A. Hall, J. Le Quesne, K.A. Jabbar, M. al Bakir, R. Hills, S. Irshad, Y. Yuan, Z. Li, M. Liu, J. Klein, O. Fadare, A. Thompson, A.J. Lazar, A. Gown, A. Lo, A.C. Garrido Castro, A. Madabhushi, A. Moreira, A. Richardson, A.H. Beck, A.M. Bellizzi, A. Wolff, A. Harbhajanka, A. Sharma, A. Cimino-Mathews, A. Srinivasan, B. Singh, C.S. Chennubhotla, C. Chauhan, D.A. Dillon, D. Zardavas, D.B. Johnson, A.E. Thompson, E. Brogi, E. Reisenbichler, E. Huang, F.R. Hirsch, H. McArthur, J. Ziai, J. Brock, J. Kerner, J. Zha, J.K. Lennerz, J.M. Carter, J. Reis-Filho, J. Sparano, J.M. Balko, K. Pogue-Geile, K.E. Steele, K.R.M. Blenman, K.H. Allison, L. Pusztai, L. Cooper, V.M. Estrada, M. Flowers, M. Robson, M.C. Rebelatto, M.G. Hanna, M.P. Goetz, M. Khojasteh, M.E. Sanders, M.M. Regan, M. Misialek, M. Amgad, N. Tung, R. Singh, R. Huang, R.H. Pierce, R. Leon-Ferre, S. Swain, S. Ely, S.-. Kim, S. Bedri, S. Paik, S. Schnitt, T. d'Alfons, U. Kurkure, V. Bossuyt, W. Tong, Y. Wang, C.H. Dos Anjos, F. Gaire, P.J. Van Diest. - In: NPJ BREAST CANCER. - ISSN 2374-4677. - 7:1(2021 Dec 01), pp. 150.1-150.17. [10.1038/s41523-021-00346-1]

The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

G. Viale
Membro del Collaboration Group
;
G. Pruneri
Membro del Collaboration Group
;
G. Curigliano;
2021-12-01

Abstract

The advent of immune-checkpoint inhibitors (ICI) in modern oncology has significantly improved survival in several cancer settings. A subgroup of women with breast cancer (BC) has immunogenic infiltration of lymphocytes with expression of programmed death-ligand 1 (PD-L1). These patients may potentially benefit from ICI targeting the programmed death 1 (PD-1)/PD-L1 signaling axis. The use of tumor-infiltrating lymphocytes (TILs) as predictive and prognostic biomarkers has been under intense examination. Emerging data suggest that TILs are associated with response to both cytotoxic treatments and immunotherapy, particularly for patients with triple-negative BC. In this review from The International Immuno-Oncology Biomarker Working Group, we discuss (a) the biological understanding of TILs, (b) their analytical and clinical validity and efforts toward the clinical utility in BC, and (c) the current status of PD-L1 and TIL testing across different continents, including experiences from low-to-middle-income countries, incorporating also the view of a patient advocate. This information will help set the stage for future approaches to optimize the understanding and clinical utilization of TIL analysis in patients with BC. (Group author: Int Immuno-Oncology Biomarker)
Settore MED/08 - Anatomia Patologica
Article (author)
File in questo prodotto:
File Dimensione Formato  
tale of tils.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 2.15 MB
Formato Adobe PDF
2.15 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/895355
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 22
  • ???jsp.display-item.citation.isi??? 12
social impact